Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Clinical Insights

Clinical Insights
A Study of Transarterial Chemoembolization in Elderly Patients: An Interview With Daniel B. Brown, MD, FSIR
11/26/2014
Older patients are often considered high-risk patients for medical procedures. Interventional oncology clinicians sought to answer the question: is transarterial chemoembolization (TACE) as safe and effective for elderly patients as it is for...
Older patients are often considered high-risk patients for medical procedures. Interventional oncology clinicians sought to answer the question: is transarterial chemoembolization (TACE) as safe and effective for elderly patients as it is for...
Older patients are often...
11/26/2014
IO Learning
Clinical Insights
Transarterial Chemoembolization and CT-Guided Ablation for Hepatic and Infrarenal Masses
10/14/2014
Abstract: We report a case of a 60-year-old patient with dyslipidemia, obesity, Child B alcoholic liver cirrhosis, and hepatocellular carcinoma (HCC). Magnetic resonance imaging revealed a 3.5 cm HCC located at liver segment VI and an...
Abstract: We report a case of a 60-year-old patient with dyslipidemia, obesity, Child B alcoholic liver cirrhosis, and hepatocellular carcinoma (HCC). Magnetic resonance imaging revealed a 3.5 cm HCC located at liver segment VI and an...
Abstract: We report a case of a...
10/14/2014
IO Learning
Clinical Insights
The STAR Tumor Ablation System for Metastatic Spinal Tumors: An Interview With Clifford Howard Jr., MD
10/09/2014
Historically, treatment for painful spinal metastases has been conservative, with most providers relying on radiation or narcotic pain management. Radiofrequency ablation (RFA) with the STAR Tumor Ablation System (DFINE) was developed...
Historically, treatment for painful spinal metastases has been conservative, with most providers relying on radiation or narcotic pain management. Radiofrequency ablation (RFA) with the STAR Tumor Ablation System (DFINE) was developed...
Historically, treatment for...
10/09/2014
IO Learning
Clinical Insights
The Intersection of Palliative Care and Interventional Oncology: An Interview With Sean Tutton, MD
08/18/2014
View video of this interview.The 39th Annual Meeting of the Society of Interventional Radiology (SIR) addressed a comprehensive array of clinical issues facing interventional radiologists, including a growing need for training in...
View video of this interview.The 39th Annual Meeting of the Society of Interventional Radiology (SIR) addressed a comprehensive array of clinical issues facing interventional radiologists, including a growing need for training in...
View video of this interview.The...
08/18/2014
IO Learning
Clinical Insights
Expanding the Role of the Registered Nurse in Interventional Oncology
08/18/2014
Interventional Oncology (IO) is a growing subspecialty of interventional radiology (IR) with focus on minimally invasive locoregional treatments, such as transarterial chemoembolization (TACE) of liver malignancies, percutaneous ablations,...
Interventional Oncology (IO) is a growing subspecialty of interventional radiology (IR) with focus on minimally invasive locoregional treatments, such as transarterial chemoembolization (TACE) of liver malignancies, percutaneous ablations,...
Interventional Oncology (IO) is...
08/18/2014
IO Learning
Clinical Insights
The Miami Cancer Meeting: An Interview With Luis E. Raez, MD
07/24/2014
Eleven years ago, Luis E. Raez, MD, was a professor of oncology at the University of Miami and had founded the lung cancer program at the university. At the time, he and his colleagues recognized the need for a comprehensive cancer conference...
Eleven years ago, Luis E. Raez, MD, was a professor of oncology at the University of Miami and had founded the lung cancer program at the university. At the time, he and his colleagues recognized the need for a comprehensive cancer conference...
Eleven years ago, Luis E. Raez,...
07/24/2014
IO Learning
Clinical Insights
MADIT-CHIC: Cardiac Resynchronization Therapy in the Treatment of Chemotherapy-Induced Cardiomyopathy
07/09/2014
According to the National Cancer Institute, approximately 14 million Americans with a history of cancer were alive in 2012. Survival from cancer has improved significantly over the last several decades due in large part to advances in...
According to the National Cancer Institute, approximately 14 million Americans with a history of cancer were alive in 2012. Survival from cancer has improved significantly over the last several decades due in large part to advances in...
According to the National Cancer...
07/09/2014
IO Learning
Clinical Insights
Yttrium-90 Therapy for Hepatic Breast Cancer Metastases: An Interview With Robert J. Lewandowski, MD, FSIR
06/26/2014
At the 39th Society for Interventional Radiology (SIR) Annual Scientific Meeting in San Diego, Robert J. Lewandowski, MD, FSIR, presented results from a study of yttrium-90 radioembolization for breast cancer metastases in the liver. The...
At the 39th Society for Interventional Radiology (SIR) Annual Scientific Meeting in San Diego, Robert J. Lewandowski, MD, FSIR, presented results from a study of yttrium-90 radioembolization for breast cancer metastases in the liver. The...
At the 39th Society for...
06/26/2014
IO Learning
Clinical Insights
Current Status and Future Directions of Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
06/23/2014
Abstract: Introduction: The appropriate sequence and timing of currently available therapies for patients with peritoneal carcinomatosis of gastrointestinal origin continue to be debated among medical and surgical oncologists. Material and...
Abstract: Introduction: The appropriate sequence and timing of currently available therapies for patients with peritoneal carcinomatosis of gastrointestinal origin continue to be debated among medical and surgical oncologists. Material and...
Abstract: Introduction: The...
06/23/2014
IO Learning
Clinical Insights
The Society of Interventional Radiology Meeting for Interventional Oncology Clinicians: An Interview With John Fritz Angle, MD
06/03/2014
At the 2014 Society of Interventional Radiology (SIR) meeting, Interventional Oncology 360 spoke with scientific program chair John Fritz Angle, MD, about the clinical programming at the meeting and opportunities for those interested in...
At the 2014 Society of Interventional Radiology (SIR) meeting, Interventional Oncology 360 spoke with scientific program chair John Fritz Angle, MD, about the clinical programming at the meeting and opportunities for those interested in...
At the 2014 Society of...
06/03/2014
IO Learning

Advertisement

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement